Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, FDA issued new guidance on its Prescription Drug User Fee Amendments (PDUFA VII) program…
Source: www.raps.org – Read more
Early Submitters Exhibit Diversity in New 10K Cyber-Disclosure Reports
Hey there, coming to you from the heart of the Bay Area! Let’s chat a bit about the new SEC cyber-security rules and how companies
